First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non–Small-Cell Lung Cancer: Are We Ready to Use It?

Dipesh Uprety, Jordi Remon, Solange Peters

Résultats de recherche: Contribution à un journal › !!Comment/debate

1 Citation (Scopus)

langue originale	Anglais
Pages (de - à)	378-382
Nombre de pages	5
journal	Journal of Clinical Oncology
Volume	42
Numéro de publication	4
Les DOIs	https://doi.org/10.1200/JCO.23.01524
état	Publié - 1 févr. 2024

Accès au document

@article{c74cfb9168c44495bf2765c818bf651a,

title = "First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non–Small-Cell Lung Cancer: Are We Ready to Use It?",

author = "Dipesh Uprety and Jordi Remon and Solange Peters",

year = "2024",

month = feb,

day = "1",

doi = "10.1200/JCO.23.01524",

language = "English",

volume = "42",

pages = "378--382",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

number = "4",

}

TY - JOUR

T1 - First-Line Dual Immunotherapy, a Treatment Option in First-Line Metastatic Non–Small-Cell Lung Cancer

T2 - Are We Ready to Use It?

AU - Uprety, Dipesh

AU - Remon, Jordi

AU - Peters, Solange

PY - 2024/2/1

Y1 - 2024/2/1

UR - http://www.scopus.com/inward/record.url?scp=85183975895&partnerID=8YFLogxK

U2 - 10.1200/JCO.23.01524

DO - 10.1200/JCO.23.01524

M3 - Comment/debate

C2 - 38033277

AN - SCOPUS:85183975895

SN - 0732-183X

VL - 42

SP - 378

EP - 382

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 4

ER -